Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) – opening of the peri‐operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial

This publication has 9 references indexed in Scilit:

• The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC)
  Urologic Oncology: Seminars and Original Investigations, 2013
• Prevention of Bladder Tumours after Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinoma: A Prospective, Multicentre, Randomised Clinical Trial of a Single Postoperative Intravesical Dose of Mitomycin C (the ODMIT-C Trial)
  European Urology, 2011
• European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update
  European Urology, 2011
• Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)
  Trials, 2011
• Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005
  BJU International, 2010
• Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration
  Journal of Urology, 2009
• Nephroureterectomy for Transitional Cell Carcinoma – The Value of Pre-Operative Histology
  The Annals of The Royal College of Surgeons of England, 2008
• Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data
  European Urology, 2005
• Neoadjuvant Chemotherapy for Locally Advanced Urothelial Cancer of the Upper Urinary Tract
  Urologia Internationalis, 1995